213 related articles for article (PubMed ID: 28554769)
1. Immunohistochemical expression of p16, Ki-67 and p53 in cervical lesions - A systematic review.
Silva DC; Gonçalves AK; Cobucci RN; Mendonça RC; Lima PH; Cavalcanti G
Pathol Res Pract; 2017 Jul; 213(7):723-729. PubMed ID: 28554769
[TBL] [Abstract][Full Text] [Related]
2. Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma.
Feng W; Xiao J; Zhang Z; Rosen DG; Brown RE; Liu J; Duan X
Mod Pathol; 2007 Sep; 20(9):961-6. PubMed ID: 17632454
[TBL] [Abstract][Full Text] [Related]
3. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.
Kuo KT; Chang HC; Hsiao CH; Lin MC
Br J Ophthalmol; 2006 Jul; 90(7):894-9. PubMed ID: 16540490
[TBL] [Abstract][Full Text] [Related]
4. Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study.
Prigenzi KCK; Heinke T; Salim RC; Focchi GRA
Acta Cytol; 2018; 62(2):104-114. PubMed ID: 29566392
[TBL] [Abstract][Full Text] [Related]
5. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Treatment Reproducibility of Cervical Intraepithelial Neoplasia / Squamous Intraepithelial Lesion and Factors Affecting the Diagnosis.
Sağlam A; Usubütün A; Dolgun A; Mutter GL; Salman MC; Kurtulan O; Akyol A; Özkan EA; Baykara S; Bülbül D; Calay Z; Eren F; Gümürdülü D; Haberal N; Ilvan Ş; Karaveli Ş; Koyuncuoğlu M; Müezzinoğlu B; Müftüoğlu KH; Özen Ö; Özdemir N; Peştereli E; Ulukuş Ç; Zekioğlu O
Turk Patoloji Derg; 2017; 1(1):177-191. PubMed ID: 28832077
[TBL] [Abstract][Full Text] [Related]
7. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
8. An immunohistochemical analysis of sex-steroid receptors, tumor suppressor gene p53 and Ki-67 in the normal and neoplastic uterine cervix squamous epithelium.
Nikolaou M; Koumoundourou D; Ravazoula P; Papadopoulou M; Michail G; Decavalas G
Med Pregl; 2014; 67(7-8):202-7. PubMed ID: 25151759
[TBL] [Abstract][Full Text] [Related]
9. Utility of Ki-67 and p53 in distinguishing cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix.
Tan GC; Sharifah NA; Shiran MS; Salwati S; Hatta AZ; Paul-Ng HO
Asian Pac J Cancer Prev; 2008; 9(4):781-4. PubMed ID: 19256776
[TBL] [Abstract][Full Text] [Related]
10. Three-tiered score for Ki-67 and p16
van Zummeren M; Leeman A; Kremer WW; Bleeker MCG; Jenkins D; van de Sandt M; Heideman DAM; Steenbergen R; Snijders PJF; Quint WGV; Berkhof J; Meijer CJLM
J Clin Pathol; 2018 Nov; 71(11):981-988. PubMed ID: 30012698
[TBL] [Abstract][Full Text] [Related]
11. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
[TBL] [Abstract][Full Text] [Related]
12. Utility of CK7 Versus p16 as a Prognostic Biomarker in CIN 2.
Umphress B; Sanchez B; Paintal A; Nayar R; Maniar KP
Am J Surg Pathol; 2018 Apr; 42(4):479-484. PubMed ID: 29438168
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer.
Celewicz A; Celewicz M; Wężowska M; Chudecka-Głaz A; Menkiszak J; Urasińska E
Pol J Pathol; 2018; 69(1):42-47. PubMed ID: 29895125
[TBL] [Abstract][Full Text] [Related]
14. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
[TBL] [Abstract][Full Text] [Related]
15. Expressions of survivin, P16(INK4a), COX-2, and Ki-67 in cervical cancer progression reveal the potential clinical application.
Zhou WQ; Sheng QY; Sheng YH; Hou WJ; Xu GX; Wu YM; Lu H
Eur J Gynaecol Oncol; 2015; 36(1):62-8. PubMed ID: 25872337
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions.
Focchi GR; Silva ID; Nogueira-de-Souza NC; Dobo C; Oshima CT; Stavale JN
J Low Genit Tract Dis; 2007 Apr; 11(2):98-104. PubMed ID: 17415114
[TBL] [Abstract][Full Text] [Related]
17. Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.
Kanthiya K; Khunnarong J; Tangjitgamol S; Puripat N; Tanvanich S
Asian Pac J Cancer Prev; 2016; 17(7):3201-6. PubMed ID: 27509952
[TBL] [Abstract][Full Text] [Related]
18. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
Liou S; Nilforoushan N; Kang Y; Moatamed NA
Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
[TBL] [Abstract][Full Text] [Related]
19. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
[TBL] [Abstract][Full Text] [Related]
20. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
